Robin Tharakan
Impact in
-
- Prostate Cancer Treatment and Research
-
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
Papers in
-
- Protein Degradation and Inhibitors 2
- Retinoids in leukemia and cellular processes 1
- PI3K/AKT/mTOR signaling in cancer 1
-
- Prostate Cancer Treatment and Research 3
- Prostate Cancer Diagnosis and Treatment 1
- Co-authors
- David W. Singleton (1 shared paper)Rakesh Kumar (1 shared paper)SA Khan (1 shared paper)Peter S. Nelson (3 shared papers)Michael D. Nyquist (3 shared papers)Elahe A. Mostaghel (3 shared papers)Eva Corey (3 shared papers)Sander B. Frank (1 shared paper)
- Journals
- Molecular Cancer Research (2 papers)Journal of Clinical Investigation (1 paper)Molecular and Cellular Endocrinology (1 paper)
- Partner nations
- United StatesSouth Africa
In The Last Decade
Robin Tharakan
4 papers receiving 121 citations
Peers
Comparison fields: 5 of 31
- Pulmonary and Respiratory Medicine 56
- Oncology 46
- Genetics 43
- Cancer Research 16
- Molecular Biology 68
Countries citing papers authored by Robin Tharakan
This map shows the geographic impact of Robin Tharakan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Tharakan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Tharakan more than expected).
Fields of papers citing papers by Robin Tharakan
This network shows the impact of papers produced by Robin Tharakan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Tharakan. The network helps show where Robin Tharakan may publish in the future.
Co-authors
The 22 scholars most cited alongside Robin Tharakan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 67 | |
| 2 | 2008 | 38 | |
| 3 | 2017 | 15 | |
| 4 | 2017 | 2 |
About Robin Tharakan
Robin Tharakan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Endocrinology, Diabetes and Metabolism and Genetics, having authored 4 papers that have together received 122 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (3 papers), Protein Degradation and Inhibitors (2 papers), PARP inhibition in cancer therapy (2 papers), Retinoids in leukemia and cellular processes (1 paper), Prostate Cancer Diagnosis and Treatment (1 paper), Estrogen and related hormone effects (1 paper), PI3K/AKT/mTOR signaling in cancer (1 paper) and Hormonal and reproductive studies (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (56 citations), Oncology (46 citations), Genetics (43 citations), Cancer Research (16 citations) and Molecular Biology (68 citations). Robin Tharakan has collaborated with scholars based in United States and South Africa. Frequent co-authors include David W. Singleton, Rakesh Kumar, SA Khan, Peter S. Nelson, Michael D. Nyquist, Elahe A. Mostaghel, Eva Corey, Sander B. Frank, Emmanuel S. Antonarakis and Samuel R. Denmeade. Their work appears in journals such as Molecular Cancer Research, Journal of Clinical Investigation and Molecular and Cellular Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.